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A B S T R A C T   
Background: The identification of dysfunctional human apolipoprotein A-I (apoA-I) in atherosclerotic plaques 
suggests that protein structure and function may be hampered under a chronic pro inflammatory scenario. 
Moreover, the fact that natural mutants of this protein elicit severe cardiovascular diseases (CVD) strongly 
indicates that the native folding could shift due to the mutation, yielding a structure more prone to misfold or 
misfunction. To understand the events that determine the failure of apoA-I structural flexibility to fulfill its 
protective role, we took advantage of the study of a natural variant with a deletion of the residue lysine 107 
(K107del) associated with atherosclerosis. 
Methods: Biophysical approaches, such as electrophoresis, fluorescence and spectroscopy were used to char-
acterize proteins structure and function, either in native conformation or under oxidation or intramolecular 
crosslinking. 
Results: K107del structure was more flexible than the protein with the native sequence (Wt) but interactions 
with artificial membranes were preserved. Instead, structural restrictions by intramolecular crosslinking im-
paired the Wt and K107del lipid solubilization function. In addition, controlled oxidation decreased the yield of 
the native dimer conformation for both variants. 
Conclusions: We conclude that even though mutations may alter protein structure and spatial arrangement, the 
highly flexible conformation compensates the mild shift from the native folding. Instead, post translational apoA- 
I modifications (probably chronic and progressive) are required to raise a protein conformation with significant 
loss of function and increased aggregation tendency. 
General significance: The results learnt from this variant strength a close association between amyloidosis and 
atherosclerosis.   
1. Introduction 
An extensive research field supports a key role of human high 
density lipoproteins (HDL) and their major protein apolipoprotein A-I 
(apoA-I) in the protection against cardiovascular disease [1,2]. An 
overall agreement highlights their beneficial participation in the re-
verse cholesterol transport (RCT), which delivers excess of cholesterol 
from peripheral cells to the liver for its catabolism [3]. In addition, it 
has been recognized the crucial participation of HDL and apoA-I in 
pathways protecting endothelial functions: stimulation of nitric oxide- 
mediated vasodilatation [4], reduction of vascular cell adhesion mole-
cule-1 (VCAM-I) expression [5,6], and inhibition of apoptosis 
promoting proliferation [7]. The multiple functions of apoA-I have been 
extensively related to its highly flexible structure. Also, a dynamic in-
terconversion between lipid-free and lipid-bound states mediates its 
efficiency to interact with membranes and recruit phospholipids and 
cholesterol. Most of the protein circulates bound as complex HDL par-
ticles, and a minor fraction, about 5% is recycled as the lipoprotein is 
catabolized, yielding lipid-free or lipid-poor conformations which are 
more effective to interact with key proteins such as ATP-binding cas-
sette proteins A1 and G1 (ABCA1 and ABCG1 receptors) and lecithin: 
cholesterol acyltransferase (LCAT) ([8] and references described there). 
Moreover, many other functions of apoA-I have been identified in vitro, 
suggesting that the protein mimics some of the pathways observed for 
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HDL, as decreasing the respiratory burst induced by oxidized low 
density lipoproteins (oxLDL) [9] and binding to bacterial lipopoly-
saccharide (LPS) [10,11]. 
Despite the aforementioned information, the “HDL-cholesterol hy-
pothesis” has been revised as it seemed to be oversimplified by setting 
an atherosclerosis-risk index from LDL/HDL ratio [8,12]. Beyond the 
usefulness of this ratio as a clinical parameter, atherosclerosis is a 
complex chronic pathological scenario, becoming a pro-oxidant en-
vironment with the release of reactive oxygen species (ROS) related to 
the failure of cholesterol homeostasis Thereby, quality of lipoproteins is 
considered to be a good predictor in addition to their quantity. Ather-
osclerotic plaques are characterized by dysfunctional apoA-I aggregated 
in the artery walls [13]. Protein distribution in human aorta is quite 
different from the circulating conformations. It is identified in high 
amounts deposited in chronic lesions predominantly lipid-poor, not 
associated with HDL, extensively oxidized and cross-linked, and func-
tionally impaired [14]. Whether protein misfolding is a cause or a 
consequence of this microenvironment is not known. In this regard, it 
was shown the presence of diffuse deposits of apoA-I as amyloid patches 
in complicated atherosclerotic plaques [15]. This fact indicates that 
amyloidosis and atherosclerosis may be closely associated [16]. 
About twenty natural variants of apoA-I have been described in-
ducing amyloidosis with deposit and failure of target organs such as 
heart, liver or kidney [17]. Interestingly, one naturally occurring de-
letion variant (K107del) was described inducing a unique pathologic 
pattern, as amyloidosis was associated with severe atherosclerosis [18]. 
The facts that determine this behavior are far to be known. The loss of 
function the increased tendency to misfold, or the ability to elicit a pro 
inflammatory environment were suggested to mediate its role in these 
diseases [19]. Taking advantage of the structural comparative study 
among K107del and the protein with the native sequence (Wt), we 
proposed here to understand the reasons that may affect apoA-I mis-
function and aggregation in the atherosclerotic plaques. Deep structural 
knowledge of this variant may help clarify the participation of apoA-I 
(or its failure to fulfill the protective roles). As oxidation and cross-
linking events are present in atherosclerotic plaques, we analyzed the 
variant's natural flexibility and function under native conditions and 
under controlled chemical modifications that could mimic those un-
dergoing in a chronic pathological scenario. 
2. Materials and methods 
2.1. Materials 
Guanidine hydrochloride (GndHCl), thioflavin T (ThT), cholesterol 
(Chol), sodium cholate, ethylenediaminetetraacetic acid (EDTA), so-
dium chloride (NaCl), sodium dodecyl sulfate (SDS),Terbium -III 
chloride (Tb) and dipicolinic acid (DPA) were from Sigma-Aldrich (St 
Louis, MO); 1-palmitoyl-2-oleoylphosphatidylcholine (POPC) and di-
myristoylphosphatidylcholine (DMPC) were purchased from Avanti 
Polar Lipids (Alabaster, AL); His-purifying resin was from Novagen 
(Darmstadt, Germany). Bis-(sulfosuccinimidyl) suberate (BS3) and iso-
propyl-β-D-thiogalactoside (IPTG) were purchased to Thermo Scientific 
(Waltham, MA). All other reagents were of the highest analytical grade 
available. 
2.2. Cloning, expression and purification of wild-type and K107del apoA-I 
Proteins were expressed as previously described in [20,21]. The 
cDNA of apoA-I with the native sequence (Wt) and K107del were 
modified to introduce an acid labile Asp-Pro peptide bond between 
amino acid residues 2 and 3 of apoA-I, which allowed specific chemical 
cleavage of an N-terminal His-Tag fusion peptide. These constructs, 
inserted into a pET-30 plasmid (Novagen, Madison, WI), were trans-
formed into BL21 (DE) Escherichia coli cells (Novagen, Madison, WI), 
then expressed by induction with IPTG and purified by elution through 
Ni-chelating columns (Novagen, Madison, WI) as described [21]. This 
resulted in a high yield of protein with a purity of at least 95% (de-
termined by SDS-PAGE). 
2.3. Crosslinking of proteins 
Proteins were crosslinked at 0.05 mg/mL in PBS pH 7.9 for 3 h 
without agitation at room temperature. Fresh BS3 was added (within 
1 min after solubilization in PBS to avoid hydrolysis of free crosslinker) 
at 30:1 BS3:protein molar ratio [22]. Reactions were quenched after 
15 min by the addition of Tris buffer to a final concentration of 50 mM. 
The concentration of crosslinked proteins was calculated by the BCA 
Protein Assay Kit (Thermo Scientific (Waltham, MA)). The presence of 
the monomeric conformation after the treatments was confirmed by 
polyacrylamide gradient electrophoresis, either under native or dena-
turing conditions. In order to evaluate whether protein oxidation may 
induce an aggregation prone conformation, proteins were incubated for 
24 h at 0.5 mg/mL and crosslinked as described above. 
2.4. Protein oxidation 
Wt and K107del were chemically oxidized by overnight incubation 
in a 10,000 M excess of H2O2 at 37 °C for 12 h. The concentration of 
H2O2 was determined spectrophotometrically (Ɛ 39.4 M−1 cm−1 at 
240 nm) [23]. Excess of H2O2 was removed by extensive dialysis 
against 10 mM sodium phosphate buffer pH 6.0 (fibrillation buffer). 
Molecular weights (Mw) of Wt and K107del oxidized proteins were 
calculated by intact protein mass spectrometry analysis. This analysis 
was performed at the Proteomics Core Facility CEQUIBIEM, at the 
University of Buenos Aires/CONICET (National Research Council). 
Samples were analyzed using an Ultraflex II Bruker Daltonics UV- 
MALDI-TOF-TOF mass spectrometer. Spectra were obtained in positive 
linear mode (LP), within a mass range of 20,000–60,000 m/z. The 
generated spectra were visualized and compared with FlexAnalysis 3.3 
software. 
2.5. Fluorescence measurements 
Tryptophan (Trp) intrinsic fluorescence emission spectra were ac-
quired on an Olis upgraded SLM4800 spectrofluorometer (ISS Inc., 
Champaign, IL). Proteins, either freshly resuspended or after chemical 
modifications were diluted to 0.05–0.2 mg/mL in Tris 20 mM pH 7.4 or 
PBS at the same pH. Excitation wavelength was fixed at 295 nm as 
previously registered [21,24]. 
2.6. Protein/lipids interaction methodologies 
2.6.1. Unilamellar liposomes construction 
One mg of POPC or (POPC:Chol at a 4:1 M ratio) from a stock so-
lution in chloroform was used to form a film in a round-bottom tube, 
dried by blowing a N2 atmosphere and exhaustively exposed to vacuum 
in a lyophilizer (Virtis) to evaporate the solvent. Then, the fluorescent 
complex [Tb-DPA] was achieved by the addition of 15 mM Tb and 
150 mM DPA in 10 mMTris pH 8.0 added to final concentration 1 mg/ 
mL of lipids. Multilamellar liposomes (MLV) were attained by extensive 
vortexing, followed by sonication to rearrange lipids into small uni-
lamellar vesicles (SUVs). Excess of the fluorescent complex was re-
moved by elution of the SUVs through a Superose 6 HR 10/30 column 
(Pharmacia) equilibrated and eluted with 10 mM Tris pH 8.0, 150 mM 
NaCl and 12.5 mM EDTA [25,26]. Only fractions showing the highest 
fluorescence yield were used within 5–7 days. 
2.6.2. Leakage measurements 
SUVs were added into the cuvette with proteins at 0.3 mg/mL, and 
homogenized by rapid pipetting (about 5 s. per sample). Then, time- 
dependent fluorescence intensity was followed for 10 min with 
I.D. Ludovico, et al.   BBA - General Subjects 1865 (2021) 129732
2
excitation and emission fixed at 250 and 544 nm, respectively. Leakage 
efficiency was calculated as a percentage of the decrease in fluorescence 
intensity (F) with respect to the initial value (Fo). The decrease of 
fluorescence induced by the addition of 1% SDS (Fo-Ft) was taken as a 
100% leakage [25,26]. Results are shown as triplicates of 3 different 
experiments. 
2.6.3. Clearance measurement 
To obtain MLV of DMPC, lipids from a stock solution in chloroform 
were dried under N2 flux as explained above, and resuspended in Tris 
buffer pH 7.4 to a final DMPC concentration of 5 mg/mL. The tube was 
vortexed at room temperature for 5 min, heating at 37 °C in 30-s cycles. 
DMPC vesicles were added to the 0.05 mg/mL proteins samples until a 
final molar ratio of 145:1 DMPC:protein. Samples were gently mixed 
(for 5 s.) and clearance was determined by monitoring Optical Density 
(DO) at 325 nm and 24 °C in a Beckman Coulter DTX 880 Microplate 
Reader (Beckman, CA). All DMPC experiments were performed in the 
presence of 0.05% sodium azide. Curves were adjusted by fitting to a 
single exponential decay y = y0 + aⅇ−bx. Next, the characterization of 
the final product was attained by 4–30% home-made native PAGGE 
developed with silver staining. The relative amount of the populations 
achieved for each variant was estimated by quantifying with the Image 
J 1.51 j8 software the associated intensity of the protein within each 
band. The relative size of the particles was also estimated by size ex-
clusion chromatography (SEC) using a Merck-Hitachi L6200 Intelligent 
pump. Samples were eluted through the Superose 6 HR 10/30 column, 
equilibrated with 50 mM Tris buffer pH 7.4 at a flow of 0.5 mL/min, 
and detected at 280 nm using a UV-VIS detector (Merck-Hitachi 
L4200). Particle morphology was characterized by transmission elec-
tron microscopy (TEM) on a JEOL-1200 EX. Samples were seeded on 
Formvard grids, contrasted with 0.5% phosphotungstic acid and vi-
sualized by negative staining. 
2.7. Other analytical methods 
Spatial arrangement of K107del was modeled using the SWISS- 
MODEL server (https://swissmodel.expasy.org, Swiss Institute of 
Bioinformatics Biozentrum, University of Basel Klingelbergstrasse, 
Basel, Switzerland) using the alignment model [27] with the apoA-I 
structural template obtained by Melchior et al. [28]. Protein structure 
figures and homology models were generated using UCSF Chimera, 
developed by the UCSF Resource for Biocomputing [29]. For most of 
the experiments, protein content was quantified by the Bradford tech-
nique [30]. For statistical analysis, datasets were analyzed in GraphPad 
Prism 8.0 software using unpaired parametric test. Only results with a 
confidence level of p  <  0.05 were considered. Unless otherwise stated, 
results either of biophysical or biological assays were reproduced in 
three independent experiments and were indicated as means of tripli-
cates ± standard deviation. Statistically significant differences between 
experimental conditions were evaluated by ANOVA or the Student's 
test. 
3. Results 
3.1. Proteins purification 
ApoA-I variants (either Wt or K107del) were isolated and purified 
from bacterial strains in high yield and purity (Suppl Fig. 1). We have 
previously shown that Wt purified under this protocol behaves almost 
indistinguishable from plasma apoA-I [20]. 
3.2. Leakage 
In order to characterize the influence of the deletion of the positive 
Lys residue in position 107 on protein function, we first compared the 
interaction of the variant with lipid bilayers, monitoring protein- 
induced leakage of SUVs. Energy transfer from DPA to Tb is highly 
efficient in the complex confined to the vesicles internal aqueous space. 
If apoA-I-induced leakage occurs, excess of EDTA present in the 
medium replaces DPA in the complex and fluorescence decreases. As 
previously observed, membrane disruption mediated by Wt was smooth 
and slow [26] (Figure1A and B). 
In order to compare both variants, leakage extension induced by 
freshly folded Wt and K107del was evaluated after 10-min interaction. 
As Fig. 1C shows, no differences were detected among both variants in 
their capacity to induce membrane permeation. Although a higher 
tendency to leakage was observed from vesicles containing Chol, the 
effect was neither significant nor different among variants, even at the 
different protein ratios tested (not shown). 
3.3. Protein chemical treatments. Oxidation and crosslinking 
3.3.1. Protein structure 
BS3 crosslinker has been widely used for the analysis of apoA-I 
structure [22]. Its short spacer arm (~11 Å) makes it suitable to 
covalently fix primary amine groups within proteins. In addition to the 
N terminal amine group, apoA-I contains a high number of Lys residues 
which may be exposed to interact with the reagent in an aqueous sol-
vent. To compare the relative efficiency of K107del to crosslink, we first 
diluted proteins at 0.5 mg/mL. Under these conditions and in agree-
ment with previous reports, Wt showed some degree of dimers cova-
lently fixed (lane 4 in Fig. 2A). This effect is less evident for the deletion 
mutant (lane 5). Afterwards, we set to determine the structural effect 
that may occur if crosslinking was restricted to intra-chain bonds. In 
this trend, proteins were set at 0.05 mg/mL, as classic studies have 
shown mainly monomer conformation present under that concentration 
[22,31], and following crosslinking protein mobility was compared by 
gradient gel electrophoresis under native conditions (PAGGE). As  
Fig. 2B shows, only monomeric species were attained. However, the 
efficiency of crosslinking was evident as treated proteins migrated 
slightly but significantly faster than the untreated ones. This observa-
tion may be explained by either a more compact conformation of cross- 
linked proteins, and/or by a gain in the net negative charge due to the 
crosslinker interaction with Lys residues. 
In order to compare whether oxidized proteins should keep the 
ability to self-associate, variants (either non-oxidized or after incuba-
tion with H2O2) were incubated at 0.5 mg/mL for 24 h at pH 6.0, then 
taken to pH 7.9, and further treated with BS3 as previously described 
(section 2.3). As it may be observed in Fig. 2C, the band corresponding 
to dimer was vanished for the oxidized species, indicating a loss in the 
oligomerization capability. 
The relative exposition of the Trp residues to the solvent may be 
used as a conformational control of protein arrangement, as it is well 
known that the high flexibility of apoA-I may be censored from the shift 
in the intrinsic fluorescence. By fixing excitation wavelength at 295 nm, 
fluorescence is dominated in average by four Trp residues (in positions 
8, 50, 72 and 108 in the native sequence) [24,32]. In agreement with 
previous reported results [32,33] the wavelength of maximum fluor-
escence of Trp (WMF) in the freshly folded K107del variant showed a 
small but significant 2 nm-shift to the red with respect to Wt. BS3- 
crosslinking did not introduce a significant structural modification as 
compared with uncrosslinked species either for Wt or K107del (Fig. 3A 
and B respectively). 
Afterwards, we analyzed the effect of oxidation on protein structure. 
We have previously described that treatment with controlled H2O2 re-
sulted in the preservation of mainly the protein molecular weight in-
tegrity but, as expected, it induced a mild tendency to oligomerize 
[19,34]. To further test whether aromatic residues could be affected 
during H2O2 oxidation, we checked intrinsic fluorescence of the oxi-
dized variants. About 4 nm-shift to the red of the WMF and a small 
decrease in intensity indicated that the aromatic residues are relatively 
more exposed in both variants but significantly preserved, as extensive 
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oxidation should result in a significant decrease in the quantum yield 
(Fig. 3C and D). 
Fluorescence was measured in an SLM 4800 spectrofluorometer 
fixing excitation wavelength at 295 nm and monitoring emission from 
310 to 400 nm. A) Wt and B) K107del at 0.05 mg/mL in PBS pH 7.9 
buffer either before (continuous lines) or after crosslinking (pointed 
lines). Spectra were normalized to the highest intensity to better com-
pare the shift in the fluorescence emission. C) Wt and D) K107del in-
trinsic fluorescence registered before (continuous lines) or after oxi-
dative treatment (dashed lines). 
In order to evaluate oxidization of K107del comparatively to Wt, we 
measured the intact mass of both non-oxidized and oxidized apoA-I 
variants through mass spectrometry (Fig. 4). Mw obtained for oxidized 
Wt (Fig. 4A, 27,857 Da) or K107del (Fig. 4B, 27,727 Da) was each 
71 Da-higher than the values obtained for the native variants [19]. 
Taking into account that sodium adducts can add +23 Da, this change 
in molecular weight is compatible with the complete oxidation of all 
methionine residues, already described for apoA-I [34,35]. The same 
global mass gain would suggest that both proteins are undergoing 
equivalent oxidative processes. In addition of a main peak corre-
sponding to the monomer, a small peak of 56 kDa may indicate a small 
amount of Wt dimer present in the sample (inset Fig. 4A). 
3.3.2. Effect of chemical modification on protein function 
With the aim of answering whether chemical modifications may 
affect proteins function, we performed a well-established test, as it is 
the ability of apoA-I to solubilize lipids from vesicles at the lipids 
transition temperature [24]. Fig. 5A shows that, in agreement with 
leakage experiments, the deletion of Lys107 did not modify the pro-
tein's efficiency to interact with DMPC. Chemical modification of pro-
teins by oxidation reflects a similar result showing no significant dif-
ferences to solubilize lipids between the oxidized Wt and K107del. 
However, oxidized proteins presented an increased capacity to clarify 
MLV liposomes with respect to the native protein conformations. Eva-
luation of the structural restriction induced by intramolecular cross-
linking resulted in drastic impairment of the variants´ ability to induce 
clearance, Wt being more affected than K107del. Significant differences 
in the clearance at the final point are compared in Fig. 5B. 
In order to evaluate the effect of the mutation on the protein ar-
rangement, particle morphology was characterized at the end of in-
cubation time (Suppl Fig. 2). Under this molar lipid:apoA-I ratio most of 
the protein, either Wt or Lys107del, rearranged into two-discrete HDL- 
like complexes of molecular weight around 500 and 300 kDa, as in-
dicated by native PAGGE and size exclusion chromatography (Suppl 
Fig. 2A). As suggested from both methodologies, a higher amount of 
apoA-I was combined in larger particles for both proteins (Suppl 
Fig. 2B). TEM images showed the classic disc-shaped populations 
Fig. 1. Leakage induced by Wt and K107del of Tb/DPA-loaded lipid vesicles. A) and B), time dependence of the fluorescence intensity change obtained by adding 
0.3 mg/mL of Wt or K107del to A) POPC or B) POPC:Chol SUVs. Fluorescence was registered with excitation set at 250 and emission at 544 nm. C) Percentage of 
leakage was calculated to the final point (last 60 s.) after 600-s. interaction. One-hundred % was taken as the decrease of fluorescence after addition of 1% SDS 
(dashed-point line in Fig. A and B). Bars represent media ± standard deviation of triplicates of three independent measurements. No differences were found between 
all conditions by evaluation by t-test (p ≤ 0.05). 
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Fig. 2. Characterization of protein crosslinking by 
polyacrylamide gel electrophoresis. Gels were run as 
described and stained with Coomasie Blue. A) SDS 
PAGE at 16% of native or crosslinked proteins at 
0.5 mg/mL. Lane 1 (Wt) and lane 2 (K107del)) be-
fore treatment with BS3; lanes 4 and 5, Wt and 
K107del after crosslinking, respectively. Lane 3 
shows SDS low molecular weight marker. Dark ar-
rows indicate the Mw expected for the apoA-I 
monomer and dimer; B) Native PAGGE (10–20%) of 
proteins crosslinked at 0.05 mg/mL. Lanes 1 and 2, 
Wt before or after crosslinking, respectively. Lanes 3 
and 4, K107del before or after crosslinking respec-
tively. Lane 5 shows commercial high molecular 
weight standard; C) SDS-PAGGE (4–16%) to com-
pare the effect of oxidation on the crosslinking effi-
ciency. Lane 1 and 4 K107del and Wt treated with 
BS3 respectively. Lanes 2 and 3 correspond to oxi-
dized Wt and K107del treated with BS3. Lane 5: Mw 
standard marker. (For interpretation of the refer-
ences to colour in this figure legend, the reader is 
referred to the web version of this article.) 
Fig. 3. Intrinsic fluorescence spectra of post-translational chemical modification of apoA-I variants.  
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(Suppl Fig. 2C). Unluckily, these images did not allow to discriminate 
their different size. Finally, and in order to better estimate a possible 
explanation for the behavior of K107del with respect to Wt, we built a 
model of the variant using as a template the recent consensus structure 
of the monomeric human apoA-I proposed from combined biophysical 
evidences [28]. As Fig. 6 indicates, our modeling predicts a distortion of 
helix 4 due to the deletion, which may weaken inter chain salt bridge 
interactions between neighbor glutamate and lysine residues. The es-
timation of solvent accessible surface area (SASA) was performed by the 
PyMOL Molecular Graphics System, Version 2.0 (Schrodinger, LLC), 
indicating a relative increase of the area exposed for K107del 
(15,936 Å2) with respect to the Wt (15,651 Å2). 
4. Discussion and conclusions 
In the present study, we set out to characterize local conditions that 
may shift apoA-I structure from the native folding, inducing its ag-
gregation and dysfunction in the atherosclerotic plaques. From the 
analysis of this chronic pro inflammatory scenario, common factors are 
to be considered: 1) chemical modifications due to reactive oxygen 
species (ROS) freed by activated macrophages, among those oxidation 
and crosslinking [34]; 2) intrinsic modifications caused by hereditary 
mutations in the apoA-I sequence which should turn it prone to misfold 
or misfunction. In this trend the deletion mutant K107del was identified 
as a good target, as it was associated with severe atherosclerosis in 
Fig. 4. Effect of oxidation on protein molecular weight. MS spectra of A) Wt and oxidized Wt and B) K107del and oxidized K107del. Inset in Fig. A) amplification of 
the peak shown by the black arrow, indicative of dimeric apoA-I. 
Fig. 5. Time-course of the interaction of native, 
crosslinked or oxidized variants with DMPC lipo-
somes. A) Multilamellar DMPC vesicles were added 
to apoA-I variants at 0.05 mg/mL, to a final molar 
ratio of 145:1 phospholipid to protein at 24 °C. Lipid 
solubilization efficiency was measured by following 
Absorbance at 325 nm. Continuous lines correspond 
to the fitting of the curves to single exponential 
decay. B) Difference among the sample's absorbance 
at the last incubation time (30 min) was estimated 
by the t-test (p ≤ 0.05). 
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patients [36,37]. Studies performed in in vitro and in vivo models have 
not completely determined either the reasons for the failure of apoA-I to 
fulfill the atheroprotective role or the increment in the severity of the 
lesions linked to the deletion variant. 
Although lower-than-normal levels of HDL were usually attributed 
to the phenotype of patients carrying apoA-I K107del [36–38], small 
clinical and biophysical differences with respect to the native protein 
were reported, and sometimes with discrepancies among the assays. 
While Rall et al. found reduced efficiency to activate LCAT of isolated 
K107del in vitro [39], this function was shown similar to Wt in other 
studies [40,41]. In a similar trend, lipid-binding affinity was reported 
either decreased [40], or similar to Wt [42]. Cholesterol efflux from 
cultured cells was not significantly altered by the deletion [43,44]. In 
other patients this mutant was associated with hypertriglyceridemia 
[38], and in vitro studies supported an increased binding to triglyceride- 
rich particles [42]. These findings suggest that, in addition to the lower 
efficiency that the mutation may induce in the normal apoA-I functions, 
the effect does not seem to be drastic. Instead, Wt protein that is also 
present in heterozygote subjects with a dissimilar prevalence of the 
mutated over the normal allele in all affected individuals may coun-
terbalance minor shifts, which could explain -at least in part- the 
variety in the patients observations. 
Here we first tested the hypothesis that the lack of the positive re-
sidue in position 107 induces a structural shift affecting protein folding 
and function. In accordance with previous reports [32,42], our data 
support a more flexible structure induced by the deletion. The lower 
efficiency of inter-chain crosslinking at concentrations greater than 
0.1 mg/mL (Fig. 2A) may indicate a tridimensional protein folding that 
is more relaxed than Wt. In agreement with this, a small amount of Wt 
dimer could be detected in the Mass Spec analysis (inset in Fig. 4A) 
which is absent for the deletion mutant. The small red shift in the in-
trinsic Trp fluorescence of K107del shown here and the increased 
binding to ANS and Bis-ANS probes previously reported [19] also 
support a more flexible structure of the monomeric conformation. 
Based on the class A model of alpha helices, Lys 107 should occur in 
a segment of the repeating 22-residue amphiphilic helices [45]. The 
traditional helix wheel simulations predict that the deletion of this re-
sidue induces a ~ 90o shift of helix axe, disrupting the nature and or-
ientation of the hydrophobic face [39]. More recently, analysis based 
on the reported crystallographic structure of the C-terminal truncated 
apoA-I [46] suggested that this mutation would induce a weakening of 
the salt bridge networks [42]. To better strength this observation, we 
modeled and compared Wt and K107del by the SWISS MODEL pre-
dictor. As Fig. 6 suggests, a less compact domain might be generated 
due to the absence of that residue. Whether one or all the models 
predict the effect of the mutation is not known and must be further 
studied. 
Despite the observed structural shift, neither lipid solubilization nor 
leakage of vesicles is significantly affected by the mutation. As the 
structural framework adopted by synthetic HDL was shown to closely 
resemble that of particles isolated in vivo [47] we intended to char-
acterize the product of the interactions of the variants with DMPC 
(Suppl Fig. 2). It may be hypothesized that the mutation disrupts the 
natural arrangement of apoA-I impacting on HDL functionality. In this 
regard, it was proposed that the two molecules of apoA-I may adopt 
different registries within the particles [48,49] but the most efficient 
LCAT activation requires its interaction with a hybrid epitope involving 
the 6/4 helices of apoA-I of the two antiparallel molecules [49]. This 
hypothesis is supported by the finding that natural or artificial mutants 
in helices 4 (as it is the case of Lys107), or helices 5 or 6 show impaired 
LCAT activation [39]. In our hands, the product of the rearrangement of 
Lys107del with DMPC did not drastically differ from the Wt, which is in 
agreement with reports showing minor perturbations in the cholesterol 
efflux [43]. However, this fact does not preclude that under special 
conditions (probably lower lipid-to-protein ratios or other lipid com-
positions) the abnormalities in lipoprotein migration detected in some 
patients may be manifested. As Cooke et al. proposed, there might be a 
“a thumbwheel-like” mechanism of apoA-I on HDL particles, depending 
on particle lipid composition and diameter that may shift the helical 
registry [49]. 
The finding of dysfunctional HDL and apoA-I in the atherosclerosis 
plaque suggests that the protein may be a victim of the pro-in-
flammatory scenario. As we herein show, lipid function under in-
tramolecular crosslinking is impaired being Wt more restrained from 
lipid solubilization than K107del (Fig. 5). In concordance with previous 
reports [32], the higher flexibility of K107del lipid-free protein may 
allow its reorganization as recruiting lipids even under some structural 
restraints following crosslinking. It remains to be determined if this 
effect on K107del is caused by crosslinking of non-crucial residues in-
volved in the interaction with lipid domains or due to the major flex-
ibility of mutant allowing to uncrosslink flexible-key domains (helices) 
to form the belt in discoidal HDL. In order to confirm this, specific 
experiments remain to be carried out in order to review the role of the 
amino group in position 107. 
In addition to croslinking, another critical post translational mod-
ification is worth to be considered such as oxidation. In this trend we 
first set to analyze the probable loss in the efficiency of lipid solubili-
zation. Instead, an increase in lipid binding affinity is observed as Wt 
Fig. 6. Model of the apoA-I Wt and K107del struc-
tural arrangement. Crystallographic structure of A) 
apoA-I Wt or B) K107del modeled using the SWISS- 
MODEL server (https://swissmodel.expasy.org), 
with the apoA-I structural template obtained from 
Melchior et al. [28]. Protein main chain is shown in 
ribbon diagram. Both images show the amino acids 
lysine and glutamate in the form of balls and sticks. 
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(and similarly observed for K107del) is oxidized under our experi-
mental conditions, which is in accordance with Panzenböck observa-
tions on Wt [50]. The reasons for this behavior are not known but, as 
they suggest, it may be hypothesized that the introduction of a negative 
charge (sulfoxide groups) in the place of non polar Met at the boundary 
between a polar and non-polar faces may alter lipid-binding affinity 
[50]. In this trend, we have recently reported a similar behavior as the 
non-polar Leu was substituted by a polar Arg [51]. 
Oxidation may also affect protein native folding. A loss in the ca-
pacity to acquire a functional dimer conformation (as shown in Fig. 2C) 
or a higher tendency to aggregate of the oxidized variant may induce 
not only the impairment in protein function, but in addition to yield a 
cytotoxic species that could worsen the pro-inflammatory scenario. In 
this regard, we have recently shown that oxidized K107del is more 
sensitive than Wt to yield amyloid fibrils which elicit neutrophils ac-
tivation [19]. 
As a conclusion, we suggest that it is required a drastic protein 
processing within the microenvironment, probably due to oxidations, 
crosslinkings, or both processes synergizing to induce a collapse of 
protein structure. This might be associated with either the loss of pro-
tein function (as lipid-binding), or its aggregation as amyloid com-
plexes. 
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